Questcor Pharmaceuticals Inc. (QCOR) announced Monday morning that it has become aware of a U.S. government investigation involving the Company's promotional practices.
Questcor Pharmaceuticals gapped open sharply lower Monday and has continued to fall in early trade. Shares are now down 9.07 at $21.06 on above average volume. The stock has dropped to a new low for the year.
Questcor Pharmaceuticals sank sharply on September 19th, following reports that Aetna (AET) dropped nearly all of its coverage of Questcor's H.P. Acthar Gel.
For comments and feedback: editorial@rttnews.com